Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Leveraging haplotype information in heritability estimation and polygenic prediction

Improving polygenic prediction from summary data by learning patterns of effect sharing across multiple phenotypes

Improving genetic risk prediction by leveraging pleiotropy

Accurate Haplotype Inference for Multiple Linked Single-Nucleotide Polymorphisms Using Sibship Data

Deep learning for polygenic prediction: The role of heritability, interaction type and sample size

Effective Genetic Risk Prediction Using Mixed Models

A Probabilistic Model to Predict Clinical Phenotypic Traits from Genome Sequencing

Leveraging Effect Size Distributions to Improve Polygenic Risk Scores Derived from Summary Statistics of Genome-Wide Association Studies.

Leveraging functional genomic annotations and genome coverage to improve polygenic prediction of complex traits within and between ancestries

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Genomic Prediction of Complex Disease Risk

FastImpute: A Baseline for Open-source, Reference-Free Genotype Imputation Methods -- A Case Study in PRS313

Towards fair and clinically relevant polygenic predictions

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

HAPNEST: efficient, large-scale generation and evaluation of synthetic datasets for genotypes and phenotypes

Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions

Polygenic risk scores: from research tools to clinical instruments

Sourcing Bivariate Genetic Overlap for Polygenic Prediction using MiXeR-Pred

A Machine-Learning Heuristic to Improve Gene Score Prediction of Polygenic Traits

Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer

Estimating Heritability and Genetic Correlations from Large Health Datasets in the Absence of Genetic Data